Surmodics, Inc. (SRDX)

Nov 19, 2025 - SRDX was delisted (reason: acquired by GTCR affiliate)

42.98

+0.15 (0.35%)

Inactive · Last trade price on Nov 18, 2025

Surmodics Financials Overview

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Revenue & Profits

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020
Revenue	120.8	126.08	132.58	99.95	105.14	94.86
Revenue Growth	-0.02%	-4.91%	32.65%	-4.93%	10.83%	-5.21%
Gross Profit	88.3	93.05	107.62	79.61	87.96	79.55
Operating Income	-12.35	-5.65	5.15	-22.1	6.7	-1.25
Net Income	-17.63	-11.54	-1.54	-27.27	4.24	1.12
Earnings Per Share	-1.24	-0.82	-0.11	-1.96	0.30	0.08
EPS Growth	-	-	-	-	275.00%	-85.45%

Revenue by Segment

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020
Medical Device	97.51	105.78	72.39	78.25	71.4
In Vitro Diagnostics	28.57	26.8	27.56	26.88	23.46

Cash & Debt

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020
Cash & Investments	32.73	40.11	45.35	19	38.87	61.1
Total Debt	29.67	29.55	29.41	10	10	0
Net Cash (Debt)	3.06	10.56	15.95	9	28.87	61.1
Net Cash Growth	-64.63%	-33.79%	77.23%	-68.83%	-52.75%	10.50%
Net Cash Per Share	0.21	0.75	1.14	0.65	2.06	4.42

Cash Flow & CapEx

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020
Operating Cash Flow	-1.88	0.25	10.51	-17.22	15.39	14.01
Capital Expenditures	-1.66	-3.49	-2.92	-3.37	-5.28	-3.67
Free Cash Flow	-3.55	-3.24	7.6	-20.59	10.11	10.34
Free Cash Flow Growth	-	-	-	-	-2.21%	406.81%

Margins

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020
Gross Margin	73.09%	73.81%	81.17%	79.65%	83.66%	83.85%
Operating Margin	-10.22%	-4.48%	3.88%	-22.11%	6.38%	-1.32%
Pretax Margin	-12.16%	-5.95%	1.88%	-22.50%	6.04%	-1.53%
Profit Margin	-14.59%	-9.15%	-1.16%	-27.29%	4.03%	1.18%
FCF Margin	-2.94%	-2.57%	5.73%	-20.60%	9.62%	10.90%

Valuation

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul '26 Jul 28, 2026	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020
PE Ratio	-	-	-	-	185.33	486.37
Forward PE	-	-	-	-	85.54	-
P/FCF Ratio	-	-	59.80	-	76.44	51.45
PS Ratio	5.07	4.41	3.43	4.27	7.35	5.61